Relay Therapeutics, Inc. (RLAY) Tops Q3 EPS by 29c
Tweet
Share
E-mailGet Alerts RLAY Hot Sheet
Join SI Premium – FREE
Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q3 EPS of ($0.54), $0.29 better than the analyst estimate of ($0.83). Revenue for the quarter came in at $25.2 million versus the consensus estimate of $374.55 thousand.
For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Jefferies Starts Frencken Group Ltd. (FRKN:SP) at Buy
- Ennis (EBF) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
